Cancer vaccine market to grow at CAGR of 25% during 2009-12
A number of healthcare companies are focusing on cancer vaccine development process to enhance their profit. The research firm has identified various instances that prove that now the focus has been shifted to cancer vaccines.
At country level analysis, RNCOS has found that the US grabbed the largest share in the vaccine market in 2009. Europe is the second largest vaccine market and a major vaccine manufacturer.
Besides, the year 2009 witnessed some of the pharmaceutical companies setting up their bases in developing countries to cater their needs. The growing pharmaceutical market in these nations supported the global giants to set-up their base for vaccine production and research.
According to the research firm, the global vaccine market has been broadly studied under various segments. On the basis of segment, adult vaccines enjoy the major market share and the future will see even more rapid growth in the adult vaccine segment, particularly in cancer and addiction segments.
The report has deeply analyzed major vaccine segments. It has also studied the pediatric vaccines and therapeutics vaccines market. The study on mergers and acquisitions in the market shows that the vaccine market has attracted many pharma players from all around the world to invest in the market.
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.